Non-Executive Director
MD PhD (Berlin) 

Skills and experience

Dr Kluge’s depth of clinical research and development experience in radiochemistry, molecular imaging and clinical development is highly valued by the Board. He brings a critical mind to the requirements of clinical development of novel radionuclide-based products and devices to enable successful clinical trials and commercialisation of Telix’s pipeline assets.

Dr Kluge received his doctorate degree in Medicine from the Free University of Berlin. He is a registered physician and the author of numerous patents and publications in the field of nuclear medicine, neurology, infection and immunology.

Career summary

Dr Kluge is a Founder, General Manager and Medical Director for ABXCRO Advanced Pharmaceutical Services GmbH (since August 2002), a fullservice Contract Research Organisation (CRO) for Phase I-III biological, radiopharmaceutical and anticancer trials based in Dresden, Germany. He was also a Founder and founding CEO of ABX GmbH ( (from September 1996 to July 2002), one of the leading manufacturers of radiopharmaceutical precursors globally.